Neil Dahiya

Francis Medical Secures $80M Series C for Innovative Water Vapor Ablation Technology

Francis Medical announced today that it has successfully concluded an $80 million Series C equity financing that exceeded expectations. The round was jointly spearheaded by Arboretum Ventures and Solas BioVentures. New backers, including Orlando Health Ventures and two other strategic […]

Francis Medical Secures $80M Series C for Innovative Water Vapor Ablation Technology Read More »

FDA Greenlights Alleviant Medical’s No-Implant Heart Failure Treatment with IDE and Breakthrough Designations

Alleviant Medical has announced obtaining both FDA investigational device exemption (IDE) and breakthrough device designation for their innovative atrial shunt. Operating out of Austin, Texas, Alleviant has pioneered a unique no-implant atrial shunt designed to manage heart failure characterized by

FDA Greenlights Alleviant Medical’s No-Implant Heart Failure Treatment with IDE and Breakthrough Designations Read More »

AccurKardia Secures FDA Breakthrough Status for Innovative Hyperkalemia Detection Software

AccurKardia has announced its recent acquisition of the FDA’s breakthrough device designation for its cutting-edge AI-based software designed to detect hyperkalemia using ECG data. The AK+ Guard platform utilizes Lead I ECG readings to identify and alert both patients and

AccurKardia Secures FDA Breakthrough Status for Innovative Hyperkalemia Detection Software Read More »